Literature DB >> 23939852

Contribution of surgical specialization to improved colorectal cancer survival.

R Oliphant1, G A Nicholson, P G Horgan, R G Molloy, D C McMillan, D S Morrison.   

Abstract

BACKGROUND: Reorganization of colorectal cancer services has led to surgery being increasingly, but not exclusively, delivered by specialist surgeons. Outcomes from colorectal cancer surgery have improved, but the exact determinants remain unclear. This study explored the determinants of outcome after colorectal cancer surgery over time.
METHODS: Postoperative mortality (within 30 days of surgery) and 5-year relative survival rates for patients in the West of Scotland undergoing surgery for colorectal cancer between 1991 and 1994 were compared with rates for those having surgery between 2001 and 2004.
RESULTS: The 1823 patients who had surgery in 2001-2004 were more likely to have had stage I or III tumours, and to have undergone surgery with curative intent than the 1715 patients operated on in 1991-1994. The proportion of patients presenting electively who received surgery by a specialist surgeon increased over time (from 14·9 to 72·8 per cent; P < 0·001). Postoperative mortality increased among patients treated by non-specialists over time (from 7·4 to 10·3 per cent; P = 0·026). Non-specialist surgery was associated with an increased risk of postoperative death (adjusted odds ratio 1·72, 95 per cent confidence interval (c.i.) 1·17 to 2·55; P = 0·006) compared with specialist surgery. The 5-year relative survival rate increased over time and was higher among those treated by specialist compared with non-specialist surgeons (62·1 versus 53·0 per cent; P < 0·001). Compared with the earlier period, the adjusted relative excess risk ratio for the later period was 0·69 (95 per cent c.i. 0·61 to 0·79; P < 0·001). Increased surgical specialization accounted for 18·9 per cent of the observed survival improvement.
CONCLUSION: Increased surgical specialization contributed significantly to the observed improvement in longer-term survival following colorectal cancer surgery.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23939852     DOI: 10.1002/bjs.9227

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

1.  Predicting opportunities to increase utilization of laparoscopy for rectal cancer.

Authors:  Deborah S Keller; Jiejing Qiu; Anthony J Senagore
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

2.  Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.

Authors:  Lv Yang; Tang WenTao; Zhang ZhiYuan; Lin Qi; Luo YuXiang; Zheng Peng; Li Ke; Jia XiaoNa; Pang YuZhi; Ji MeiLing; Feng QingYang; He GuoDong; Wang YueXiang; Xu JianMin
Journal:  Oncogene       Date:  2022-05-03       Impact factor: 9.867

3.  Emergency presentation of node-negative colorectal cancer treated with curative surgery is associated with poorer short and longer-term survival.

Authors:  Raymond Oliphant; David Mansouri; Gary A Nicholson; Donald C McMillan; Paul G Horgan; David S Morrison
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

4.  Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway.

Authors:  Li-ya Su; Ying-xu Shi; Mei-rong Yan; Yaguang Xi; Xiu-lan Su
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

5.  The impact of surgical specialisation on survival following elective colon cancer surgery.

Authors:  Raymond Oliphant; Gary A Nicholson; Paul G Horgan; Donald C McMillan; David S Morrison
Journal:  Int J Colorectal Dis       Date:  2014-07-19       Impact factor: 2.571

6.  miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.

Authors:  Chaoguang Xin; Hao Zhang; Zanchao Liu
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

7.  Low anterior resection syndrome: a survey of the members of the American Society of Colon and Rectal Surgeons (ASCRS), the Spanish Association of Surgeons (AEC), and the Spanish Society of Coloproctology (AECP).

Authors:  Luis Miguel Jimenez-Gomez; Eloy Espin-Basany; Marc Marti-Gallostra; Jose Luis Sanchez-Garcia; Francesc Vallribera-Valls; Manuel Armengol-Carrasco
Journal:  Int J Colorectal Dis       Date:  2016-01-29       Impact factor: 2.571

8.  Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.

Authors:  Yaqi Li; Qianlan Yao; Long Zhang; Shaobo Mo; Sanjun Cai; Dan Huang; Junjie Peng
Journal:  Oncologist       Date:  2020-09-28

9.  Risk scoring system for recurrence after simultaneous resection of colorectal cancer liver metastasis.

Authors:  Yuchen Wu; Tianan Guo; Zhenhong Xu; Fangqi Liu; Sanjun Cai; Lu Wang; Ye Xu
Journal:  Ann Transl Med       Date:  2021-06

10.  Hospital variation in sphincter-preservation rates in rectal cancer treatment: results of a population-based study in the Netherlands.

Authors:  T Koëter; L C F de Nes; D K Wasowicz; D D E Zimmerman; R H A Verhoeven; M A Elferink; J H W de Wilt
Journal:  BJS Open       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.